Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, antibodies, Diseases, Non-Biological, Therapies, Hodgkin Lymphoma, Combinations, checkpoint inhibitors, Adverse Events, chemotherapy, enzyme inhibitors, T-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, Clinically relevant, transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, antibodies, Diseases, Non-Biological, Therapies, Hodgkin Lymphoma, Combinations, checkpoint inhibitors, Adverse Events, chemotherapy, enzyme inhibitors, T-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, Clinically relevant, transplantation
Sunday, December 6, 2020: 2:00 PM-3:30 PM
Moderators:
Patrick B. Johnston, MD/ PhD, Mayo Clinic
and
Ann S. LaCasce, MD, MSc, Dana-Farber Cancer Inst.
Disclosures:
No relevant conflicts of interest to declare.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH